– Development of guidelines and position papers: • Harmonisation of requirements for low (efficacy) and high (safety) potency and batch consistency of vaccines • Gene therapy • Vectored vaccines (when the vector is part of the vaccine) • Revision of CVMP guidance with regard to compliance with the European Pharmacopoeia • Review of equine influenza guidelines